These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16515905)

  • 1. Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses.
    Smedira NG; Blackstone EH; Roselli EE; Laffey CC; Cosgrove DM
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):558-564.e4. PubMed ID: 16515905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis after aortic valve replacement with the Carpentier-Edwards pericardial valve: use of microsimulation.
    Puvimanasinghe JP; Takkenberg JJ; Eijkemans MJ; Steyerberg EW; van Herwerden LA; Grunkemeier GL; Habbema JD; Bogers AJ
    Ann Thorac Surg; 2005 Sep; 80(3):825-31. PubMed ID: 16122436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological versus mechanical aortic prosthesis? A nineteen-year comparison in a propensity-matched population.
    Bottio T; Rizzoli G; Caprili L; Testolin L; Thiene G; Gerosa G
    J Heart Valve Dis; 2005 Jul; 14(4):493-500. PubMed ID: 16116876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitroflow pericardial valve prosthesis in the aortic position: an analysis of long-term outcome and prognostic factors.
    Minami K; Boethig D; Mirow N; Kleikamp G; Koertke H; Godehardt E; Koerfer R
    J Heart Valve Dis; 2000 Jan; 9(1):112-22. PubMed ID: 10678383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural deterioration of the Freestyle aortic valve: mode of presentation and mechanisms.
    Mohammadi S; Baillot R; Voisine P; Mathieu P; Dagenais F
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):401-6. PubMed ID: 16872969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes after aortic valve replacement using cryopreserved aortic allograft.
    Fukushima S; Tesar PJ; Pearse B; Jalali H; Sparks L; Fraser JF; Pohlner PG
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):65-72.e2. PubMed ID: 24021951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study.
    Takkenberg JJ; Klieverik LM; Bekkers JA; Kappetein AP; Roos JW; Eijkemans MJ; Bogers AJ
    Eur J Cardiothorac Surg; 2007 May; 31(5):851-9. PubMed ID: 17350857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durability of pericardial versus porcine aortic valves.
    Gao G; Wu Y; Grunkemeier GL; Furnary AP; Starr A
    J Am Coll Cardiol; 2004 Jul; 44(2):384-8. PubMed ID: 15261935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability of pericardial versus porcine bioprosthetic heart valves.
    Grunkemeier GL; Furnary AP; Wu Y; Wang L; Starr A
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1381-6. PubMed ID: 23010581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement.
    Sjögren J; Gudbjartsson T; Thulin LI
    J Heart Valve Dis; 2006 Mar; 15(2):197-202. PubMed ID: 16607900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients.
    D'Onofrio A; Auriemma S; Magagna P; Favaro A; Cannarella A; Piccin C; Bilotta M; Abbiate N; Lamascese N; Fabbri A
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):491-5. PubMed ID: 17662795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement?
    Jamieson WR; Gudas VM; Burr LH; Janusz MT; Fradet GJ; Ling H; Germann E; Lichtenstein SV
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):104-10. PubMed ID: 19056294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses.
    Brown ML; Schaff HV; Lahr BD; Mullany CJ; Sundt TM; Dearani JA; McGregor CG; Orszulak TA
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):878-84; discussion 884. PubMed ID: 18374773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term results of the surgical treatment in acute aortic valve endocarditis].
    Vogt PR; Brunner-LaRocca HP
    Z Kardiol; 2001; 90 Suppl 6():27-34. PubMed ID: 11826819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients.
    Minami K; Zittermann A; Schulte-Eistrup S; Koertke H; Körfer R
    Ann Thorac Surg; 2005 Nov; 80(5):1699-705. PubMed ID: 16242441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years.
    Yankah CA; Pasic M; Musci M; Stein J; Detschades C; Siniawski H; Hetzer R
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):688-96. PubMed ID: 18805273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Carpentier-Edwards pericardial and supraannular bioprostheses in aortic valve replacement.
    Puvimanasinghe JP; Takkenberg JJ; Eijkemans MJ; van Herwerden LA; Jamieson WR; Grunkemeier GL; Habbema JD; Bogers AJ
    Eur J Cardiothorac Surg; 2006 Mar; 29(3):374-9. PubMed ID: 16386920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CarboMedics Mitroflow pericardial aortic bioprosthesis - performance in patients aged 60 years and older after 15 years.
    Benhameid O; Jamieson WR; Castella M; Carrier M; Pomar JL; Germann E; Pellerin M; Brownlee RT
    Thorac Cardiovasc Surg; 2008 Jun; 56(4):195-9. PubMed ID: 18481236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seventeen-year clinical results of 1,037 Mitroflow pericardial heart valve prostheses in the aortic position.
    Yankah CA; Schubel J; Buz S; Siniawski H; Hetzer R
    J Heart Valve Dis; 2005 Mar; 14(2):172-9; discussion 179-80. PubMed ID: 15792176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis.
    García-Bengochea J; Sierra J; González-Juanatey JR; Rubio J; Vega M; Fernández AL; Sánchez D
    J Heart Valve Dis; 2006 May; 15(3):446-51; discussion 451-2. PubMed ID: 16784087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.